KRAS Mutations

Advancing Precision Oncology: Targeting KRAS Mutations with LUMAKRAS and KRAZATI

Advancing Precision Oncology: Targeting KRAS Mutations with LUMAKRAS and KRAZATI

SG Tylor

KRAS is a well-known oncogene that is highly prone to mutations in various cancers, including PDAC, NSCLC, and CRC. These ...

KRAS Mutations: Challenges and Breakthroughs in Cancer Treatment

KRAS Mutations: Challenges and Breakthroughs in Cancer Treatment

SG Tylor

Introduction Cancer remains a major global health concern, with various types of disease affecting millions of lives each year. One ...